COPD,
which includes chronic bronchitisand emphysema. Genome-wide association studies
have identified several genes that contribute to the COPD development, however
scientists still lack an understanding of the pathogenesis of theCOPD. The
researchers examined the link between genetic variants in COPD and clinical
phenotypes, or physical characteristics such as the historyof the disease, to
understand the biological mechanisms concealing COPD.
Using
genetic data from patients, the researchers performed a phenome-wide
association study (PheWAS) of 16 reported COPD-associated Single Nucleotide
Polymorphisms (SNPs) that were recognized by a genome-wide association study.
SNPs represent a difference in a single DNA building block called a nucleotide
are the common type of genetic variation among people.People are genetically
very similar, but the main difference is because of theSingle
Nucleotide Polymorphism (SNP).


Right
now here's no treatment for COPD, Researchers are attempting to figure out to diagnose
and to prevent it.So, some people with a specific SNP are more susceptible to
get this disease.
SNP is
also combinedwith several autoimmune diseases, likerheumatoid arthritis, type 1
diabetes thatsuggests a genetic link between COPDand autoimmune disease.
This
study could provide awareness on opportunities for drug repurposing. The
findings recommend future studies should explore the role of the immune system
in the COPDpathogenesis. The researchers hope that scientists will investigate
how normal SNPs, such as those associated with metabolic pathways or different
nutrient receptors, are related to COPD.
By William Rose
No comments:
Post a Comment